Skip to content

Clinical trials

Active, not recruiting Hematologic Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Status: Active, not recruiting Country / region: United States Clear all

97 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20131
20143
20159
201614
20178
20183
20198
202018
20218
202213
20234
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting97

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center23
National Cancer Institute (NCI)21
City of Hope Medical Center11
Fred Hutchinson Cancer Center4
Janssen Research & Development, LLC3
University of Rochester NCORP Research Base3
Bellicum Pharmaceuticals2
Children's Oncology Group2
Memorial Sloan Kettering Cancer Center2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms97
Multiple Myeloma21
Lymphoma20
Leukemia, Myeloid, Acute10
Myelodysplastic Syndromes10
Lymphoma, Non-Hodgkin7
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Hodgkin Disease5
Leukemia, Lymphocytic, Chronic, B-Cell5
COVID-194

Trials

Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.